These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 8908412)

  • 1. Effects of chronic treatment with methadone and naltrexone on sleep in addicts.
    Staedt J; Wassmuth F; Stoppe G; Hajak G; Rodenbeck A; Poser W; Rüther E
    Eur Arch Psychiatry Clin Neurosci; 1996; 246(6):305-9. PubMed ID: 8908412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultra-low dose oral naltrexone decreases side effects and potentiates the effect of methadone.
    Cruciani RA; Lussier D; Miller-Saultz D; Arbuck DM
    J Pain Symptom Manage; 2003 Jun; 25(6):491-4. PubMed ID: 12782427
    [No Abstract]   [Full Text] [Related]  

  • 3. Opioid Maintenance Therapy: A Review of Methadone, Buprenorphine, and Naltrexone Treatments for Opioid Use Disorder.
    Fipps DC; Oesterle TS; Kolla BP
    Semin Neurol; 2024 Aug; 44(4):441-451. PubMed ID: 38848746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discrimination of a single dose of morphine followed by naltrexone: substitution of other agonists for morphine and other antagonists for naltrexone in a rat model of acute dependence.
    Holtzman SG
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1033-41. PubMed ID: 12604679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of opioid antagonists in treating intravenous cocaine abuse.
    Kosten TR; Kleber HD; Morgan C
    Life Sci; 1989; 44(13):887-92. PubMed ID: 2927249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of methadone, buprenorphine, and naltrexone on actigraphy-based sleep-like parameters in male rhesus monkeys.
    Berro LF; Zamarripa CA; Talley JT; Freeman KB; Rowlett JK
    Addict Behav; 2022 Dec; 135():107433. PubMed ID: 35901553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CE: Acute Pain Management for People with Opioid Use Disorder.
    Broglio K; Matzo M
    Am J Nurs; 2018 Oct; 118(10):30-38. PubMed ID: 30211703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety, efficacy, and long-term results of a modified version of rapid opiate detoxification under general anaesthesia: a prospective study in methadone, heroin, codeine and morphine addicts.
    Hensel M; Kox WJ
    Acta Anaesthesiol Scand; 2000 Mar; 44(3):326-33. PubMed ID: 10714849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Differences in depression severity and frequency of relapses in opiate addicts treated with methadone or opiate blocker after detoxification].
    Jovanović T; Lazarević D; Nikolić G
    Vojnosanit Pregl; 2012 Apr; 69(4):326-32. PubMed ID: 22624424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An open-label study of a functional opioid kappa antagonist in the treatment of opioid dependence.
    Rothman RB; Gorelick DA; Heishman SJ; Eichmiller PR; Hill BH; Norbeck J; Liberto JG
    J Subst Abuse Treat; 2000 Apr; 18(3):277-81. PubMed ID: 10742642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Narcotic antagonists in the treatment of opioid dependence: review and commentary.
    Resnick RB; Schuyten-Resnick E; Washton AM
    Compr Psychiatry; 1979; 20(2):116-25. PubMed ID: 421447
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of street methadone in italian heroin addicts presenting for opioid agonist treatment.
    Maremmani I; Pacini M; Pani PP; Popovic D; Romano A; Maremmani AG; Deltito J; Perugi G
    J Addict Dis; 2009 Oct; 28(4):382-8. PubMed ID: 20155607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Utilization of Low Dose Naltrexone for Chronic Pain.
    Poliwoda S; Noss B; Truong GTD; Creech ZA; Koushik SS; Urits I; Viswanath O
    CNS Drugs; 2023 Aug; 37(8):663-670. PubMed ID: 37505425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. THC-methadone and THC-naltrexone interactions on discrimination, antinociception, and locomotion in rats.
    Wakley AA; Craft RM
    Behav Pharmacol; 2011 Sep; 22(5-6):489-97. PubMed ID: 21716095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is naltrexone a cure for heroin dependence?
    Hall WD; Wodak A
    Med J Aust; 1999 Jul; 171(1):9-10. PubMed ID: 10451663
    [No Abstract]   [Full Text] [Related]  

  • 16. Serious adverse events in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD).
    Digiusto E; Shakeshaft A; Ritter A; O'Brien S; Mattick RP;
    Addiction; 2004 Apr; 99(4):450-60. PubMed ID: 15049745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward a rational selection of treatment for addiction.
    O'Brien CP
    Curr Psychiatry Rep; 2007 Dec; 9(6):441-2. PubMed ID: 18221622
    [No Abstract]   [Full Text] [Related]  

  • 18. Time-dependent regional brain distribution of methadone and naltrexone in the treatment of opioid addiction.
    Teklezgi BG; Pamreddy A; Baijnath S; Kruger HG; Naicker T; Gopal ND; Govender T
    Addict Biol; 2019 May; 24(3):438-446. PubMed ID: 29441714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-opioid induction of morphine-6-glucuronide synthesis is elicited by prolonged exposure of rat hepatocytes to heroin.
    Graziani M; Antonilli L; Togna AR; Brusadin V; Viola S; Togna G; Badiani A; Nencini P
    Drug Alcohol Depend; 2008 Dec; 98(3):179-84. PubMed ID: 18597954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe opioid withdrawal syndrome after a single dose of nalmefene.
    Donnerstag N; Schneider T; Lüthi A; Taegtmeyer A; Raetz Bravo A; Mehlig A
    Eur J Clin Pharmacol; 2015 Aug; 71(8):1025-6. PubMed ID: 26050241
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.